Sprycel

Sprycel (dasatinib) is an oral medication prescribed for certain blood cancers. It belongs to the tyrosine kinase inhibitor class, supporting targeted therapy. This e-catalog provides neutral, factual details for informational purposes only.

Dasatinib is primarily used to treat specific types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by inhibiting abnormal protein signals that drive cancer cell growth. Patients often ask, 'What is dasatinib used for?' to understand its role in managing these conditions.

Dasatinib may help reduce symptoms associated with leukemia, such as fatigue or swelling. Users often report improved energy levels during treatment. Common effects include mild gastrointestinal discomfort or changes in appetite. Individual responses vary, and not all effects are experienced by everyone.

Store dasatinib at room temperature, away from moisture and direct light. Keep out of reach of children and pets. Handle with care to avoid accidental exposure. If a dose is missed, follow the prescribed schedule; do not double doses. Consult a healthcare provider for personalized guidance.

Dasatinib may interact with other medications, including certain antibiotics, antifungals, and heart medications. Grapefruit products can affect how dasatinib is processed in the body. Alcohol use should be discussed with a healthcare provider. Always inform your doctor about all medications and supplements you take.